NASDAQ: KRMDKoru Medical Systems Inc Stock
$2.62-0.07 (-2.6%)
Updated Oct 4, 2024
KRMD Price
$2.62
Fair Value Price
N/A
Market Cap
$120.14M
52 Week Low
$1.98
52 Week High
$3.09
P/E
-10.48x
P/B
6.42x
P/S
3.94x
PEG
N/A
Dividend Yield
N/A
Revenue
$30.82M
Earnings
-$11.76M
Gross Margin
62.5%
Operating Margin
-21.46%
Profit Margin
-38.2%
Debt to Equity
0.46
Operating Cash Flow
-$413k
Beta
0.87
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
KRMD Overview
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how KRMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KRMD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
KRMD is poor value based on its book value relative to its share price (6.42x), compared to the US Medical Instruments & Supplies industry average (3.97x)
P/B vs Industry Valuation
KRMD is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more KRMD due diligence checks available for Premium users.
Be the first to know about important KRMD news, forecast changes, insider trades & much more!
KRMD News
Valuation
KRMD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-10.48x
Industry
-57.71x
Market
26.83x
KRMD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.42x
Industry
3.97x
KRMD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
KRMD's financial health
Profit margin
Revenue
$8.4M
Net Income
-$988.7k
Profit Margin
-11.7%
KRMD's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
KRMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$27.3M
Liabilities
$8.6M
Debt to equity
0.46
KRMD's short-term assets ($19.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KRMD's short-term assets ($19.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KRMD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
KRMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$11.3k
Investing
-$148.5k
Financing
-$225.2k
KRMD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
KRMD vs Medical Stocks
Koru Medical Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.